Journey Medical's future hinges on Emrosi, a new formulation of minocycline for rosacea, showing superior efficacy. Read why ...

A pharmacist explains the similarities and differences between these two antibiotics Minocycline and doxycycline are ...

The drugs listed are in alphabetical order. Bendamustine hydrochloride injection: Apotex on Jan. 27 reported the discontinuation of both the 25 mg and 100 mg presentations of bendamustine ...

An increasing amount of evidence suggests that the FDA-approved antibiotic minocycline might have neuroprotective effects in animal models of various neurodegenerative disorders, and Gordon et al.

Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel ...

The FDA approved minocycline hydrochloride extended-release capsules (Emrosi) for treating inflammatory lesions of rosacea in ...

Minocycline is a tetracycline analogue that has been used in clinical trials for stroke, multiple sclerosis and several neurodegenerative conditions.

1 The trial was undertaken on the basis that minocycline has many effects on the mechanisms of neurodegeneration, including interception of several known inducers of apoptosis and the activation of ...

Minocycline is a bacteriostatic, long-acting, lipid-soluble tetracycline that is generally well tolerated, but has been associated with polyarteritis nodosa (PAN). This is a case report of a ...

Objectives: To evaluate the effect of minocycline as treatment for cutaneous calcinosis in limited cutaneous systemic sclerosis (lcSSc). Methods: Patients with lcSSc who had cutaneous calcinosis ...

Alon Scope (Memorial Sloan-Kettering Cancer Center, NY, USA) and colleagues randomly assigned 48 patients about to start cetuximab to receive oral minocycline (100 mg daily) or placebo for 8 weeks.